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ABSTRACT Host genetics plays an important role in determining the outcome of
Mycobacterium tuberculosis infection. We previously found that Collaborative Cross
(CC) mouse strains differ in their susceptibility to M. tuberculosis and that the CC042/
GeniUnc (CC042) strain suffered from a rapidly progressive disease and failed to pro-
duce the protective cytokine gamma interferon (IFN-) in the lung. Here, we used
parallel genetic and immunological approaches to investigate the basis of CC042
mouse susceptibility. Using a population derived from a CC001/Unc (CC001) 
CC042 intercross, we mapped four quantitative trait loci (QTL) underlying tuberculo-
sis immunophenotypes (Tip1 to Tip4). These included QTL that were associated with
bacterial burden, IFN- production following infection, and an IFN--independent
mechanism of bacterial control. Further immunological characterization revealed that
CC042 animals recruited relatively few antigen-specific T cells to the lung and that
these T cells failed to express the integrin alpha L (L; i.e., CD11a), which contrib-
utes to T cell activation and migration. These defects could be explained by a CC042
private variant in the Itgal gene, which encodes CD11a and is found within the Tip2
interval. This 15-bp deletion leads to aberrant mRNA splicing and is predicted to re-
sult in a truncated protein product. The ItgalCC042 genotype was associated with all
measured disease traits, indicating that this variant is a major determinant of sus-
ceptibility in CC042 mice. The combined effect of functionally distinct Tip variants
likely explains the profound susceptibility of CC042 mice and highlights the multi-
genic nature of tuberculosis control in the Collaborative Cross.
IMPORTANCE The variable outcome of Mycobacterium tuberculosis infection ob-
served in natural populations is difficult to model in genetically homogeneous small-
animal models. The newly developed Collaborative Cross (CC) represents a reproduc-
ible panel of genetically diverse mice that display a broad range of phenotypic
responses to infection. We explored the genetic basis of this variation, focusing on a
CC line that is highly susceptible to M. tuberculosis infection. This study identified
multiple quantitative trait loci associated with bacterial control and cytokine produc-
tion, including one that is caused by a novel loss-of-function mutation in the Itgal
gene, which is necessary for T cell recruitment to the infected lung. These studies
verify the multigenic control of mycobacterial disease in the CC panel, identify ge-
netic loci controlling diverse aspects of pathogenesis, and highlight the utility of the
CC resource.
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Nearly one-quarter of the world’s population has been exposed to Mycobacteriumtuberculosis, yet less than 10% of these exposures progress to clinical disease (1).
The rational design of more effective interventions requires an increased understanding
of the factors that determine the outcome of this interaction. A large body of evidence
supports an important role for host genetics in determining disease progression,
including classic twin studies (2, 3), linkage analyses (4–8), and both case-control (9, 10)
and genome-wide association (11, 12) studies. However, the genetic variants that
determine the risk of adult pulmonary disease remain elusive due to both the com-
plexity of factors influencing clinical outcomes and the lack of model systems that
reflect the diversity of natural populations.
Much of the mechanistic insight into protective immunity against M. tuberculosis
comes from mouse models of infection. Resistant strains of mice, such as the commonly
used C57BL/6J (B6) strain, are able to restrict the replication of M. tuberculosis for over
a year (13). Protective immunity in B6 mice relies heavily on Th1-biased CD4 T cell
activation and the production of gamma interferon (IFN-) in the infected tissue (14,
15). IFN- mediates its protective effect both by activating microbiocidal mechanisms
in parasitized macrophages (16–18) and by inhibiting the recruitment of granulocytes
that have been shown to exacerbate disease (19, 20). As these effects require the local
production of the cytokine, the adhesion molecules and chemokines required for T cell
recruitment play a pivotal role in immunity. Studies in knockout mice have shown that
T cell expression of the integrin L2 and the chemokine receptors CXCR3, CCR5, and
CCR2 is important for the proper positioning of these T cells and for protective
immunity in the lung (21–24).
Despite the wealth of mechanistic data that can be obtained in the mouse model,
standard lab strains of mice do not reproduce the diversity in pathogenesis observed
in natural populations. Not only does the relatively homogeneous histopathology
observed in these animals differ from the variable disease seen in patients (25), but
recent evidence suggests an unappreciated diversity in human immune responses to
M. tuberculosis (26), which have not been described in mice. For example, it now
appears that some humans have the capacity to control M. tuberculosis infection in the
absence of the IFN- response that is critical in B6 mice (27), and emerging evidence
also suggests a possible protective role for antibodies that play little role in the
standard mouse model (28, 29). Much of the previous work to increase the diversity of
tuberculosis (TB) disease in mice has focused on relatively susceptible substrains that
remain closely related to B6 mice (30). While studies contrasting these strains have
identified a number of quantitative trait loci (QTL) associated with susceptibility (31–
36), the diversity observed in these highly related strains still does not mimic the
diversity observed in an outbred population.
Recently, a number of new resources have become available to introduce additional
genetic variability into mouse model systems. For example, Diversity Outbred (DO)
mice are an outbred population of genetic mosaics based on eight inbred founders,
including highly divergent wild-derived strains (37). M. tuberculosis infection of DO mice
produces a wide range of disease manifestations, including extreme susceptibility,
which is not observed in more standard lab strains (38). While the DO population
incorporates a great deal of diversity, each genotype is represented by a single unique
mouse, limiting the mechanistic characterization that is otherwise a strength of the
mouse system. The Collaborative Cross (CC) consists of recombinant inbred lines
derived from the same eight inbred founder strains on which the DO population is
based (39). In contrast to the outbred DO population, each inbred CC strain represents
a reproducible mosaic of the founder genomes and, thus, a reproducible model of
disease (40). We have shown that the range of TB susceptibility observed in the DO
population can be recapitulated in CC mice (41). This previous work found that
CC042/GeniUnc (CC042) animals were highly susceptible to M. tuberculosis infection, in
contrast to resistant mouse strains, such as CC001/Unc (CC001) or B6 mice (41).
Here we investigated the basis of TB susceptibility in the CC042 strain using a
parallel genetic and immunophenotyping approach. By producing an intercross pop-
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ulation based on CC042 and the resistant CC001 strains, we identified multiple QTL,
named tuberculosis immunophenotypes (Tip1 to Tip4), that were differentially associ-
ated with the bacterial burden and/or IFN- production. In this population, canonical
IFN--dependent immunity was controlled by a novel mutation in the Itgal gene, which
disrupts expression of the L2 adhesion molecule and prevents the recruitment of
cytokine-expressing T cells to the site of infection. Other Tip loci were driven by
wild-derived founder alleles that either reduce IFN- production or control IFN--
independent immunity. Together, these observations explain the extreme susceptibility
of CC042 mice and indicate that the CC panel can be used to understand diverse
mechanisms of protective immunity to M. tuberculosis.
RESULTS
Control of M. tuberculosis infection in CC042 mice is lost upon the onset of
adaptive immunity. In order to dissect the mechanisms underlying CC042 suscepti-
bility to M. tuberculosis, we first profiled disease progression in aerosol-infected CC042
animals compared to the more resistant B6 mice. In the standard B6 mouse model, the
peak of bacterial burden was observed at about 21 days postinfection, coincident with
the onset of robust Th1 immunity. While CC042 mice had 10-fold lower numbers of CFU
in the lung and spleen at 14 days than B6 mice (Fig. 1A and B), CC042 animals ultimately
FIG 1 CC042 mice are susceptible to low-dose aerosol M. tuberculosis infection. The numbers of lung CFU (A), the
numbers of spleen CFU (B), body weight (C, D), and total IFN- levels in lung (E) or spleen (F) homogenates at 14,
21, 28, and 33 days after infection by low-dose aerosol (50 to 100 CFU) of M. tuberculosis strain H37Rv are shown.
All mice were infected in one batch, and 3 males and 3 females of each strain were used for analysis at each time
point. The data in the graphs represent the mean  SD. One-way analysis of variance with Sidak’s multiple-
comparison test was used to determine significance. *, P  0.05; **, P  0.01; ***, P  0.001; ****, P  0.0001; ns, not
significant.
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failed to control bacterial replication. By day 28 postinfection, the lungs of CC042
mice harbored 100-fold more bacteria than the lungs of B6 mice. Similar trends in
relative bacterial burden were observed in the spleen. All CC042 mice had lost
significant weight and required euthanasia because of morbidity by day 33 postin-
fection (Fig. 1C and D). Both male and female CC042 mice were similarly moribund
at this time point.
The superior control of bacterial replication by B6 mice correlated with IFN-
abundance in lung homogenate. There was a significant increase in IFN- levels starting
on day 21, which peaked by day 28 in all B6 mice (Fig. 1E). In contrast, the concentration
of IFN- in the lungs and spleens of CC042 mice remained relatively low throughout the
course of infection (Fig. 1E and F). Further histological comparison found cellular
infiltration in B6 mouse lung lesions that largely consisted of macrophages and
lymphocytes throughout the experiment, while necrosis and neutrophil infiltration
were apparent in CC042 mouse lungs by 21 days and were sustained until the termi-
nation of the experiment (day 33 postinfection) (Fig. 2). Together, these data suggest
that the susceptibility of CC042 mice could be related to a defect in IFN- production
that promotes bacterial growth and granulocyte infiltration.
Identifying TB susceptibility loci in a CC001  CC042 intercross. To investigate
the genetic basis of CC042 mouse susceptibility, we created an F2 population between
CC042 and CC001 mice. The CC001 strain was chosen as a partner to cross with the
CC042 strain because of its relative TB resistance (which is similar to that of B6 mice)
(41) and to match the CC042 mouse major histocompatibility locus (H-2b). We crossed
female CC001 mice with male CC042 mice to generate F1 progeny [(CC001  CC042)F1
mice], which were then intercrossed to produce 201 F2 offspring. We infected male and
female F1 and F2 progeny, along with parental strains, with M. tuberculosis (H37Rv) via
low-dose aerosol. The mice were sacrificed at between 28 and 31 days postinfection, a
time point that maximized phenotypic differences while minimizing morbidity. The
phenotypes measured included the numbers of lung CFU, the numbers of spleen CFU,
and lung IFN- levels.
For the numbers of spleen CFU and lung IFN- levels, F1 mice showed an interme-
diate phenotype and F2 mice displayed a distribution of values spanning the range for
the parental strains (Fig. 3A and B). In contrast, F1 mice had higher bacterial burdens in
the lung than the susceptible CC042 mice (Fig. 3C), and F2 mice spanned this greater
phenotypic range. The three traits covaried in a predictable manner (Fig. 3D). The
bacterial burden in lung and spleen were positively correlated. Lung IFN- levels were
more strongly associated with the numbers of CFU in the spleen than with the numbers
of CFU in the lung, consistent with the more prominent role of IFN--independent T cell
functions in the lung (42). The imperfect correlation between these traits, as well as the
FIG 2 Changes in lung pathology during M. tuberculosis infection. Lung lobes obtained from B6 and CC042 mice
at days 21, 28, and 33 postinfection were stained with hematoxylin and eosin. Images are representative of those
from 6 mice per strain per time point. (Insets) Magnified images from day 33 show lymphocytes (yellow arrow),
macrophages (red arrow), and neutrophils (green arrow).
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expansion of phenotypic ranges in F2 animals, suggested that multiple genes con-
trolled the differences between CC001 and CC042 mice.
In total, 170 F2 mice (86 female and 84 male mice) were genotyped with the
MiniMUGA array (43). We first validated our genetic mapping protocol using a coat
color trait (see Fig. S1 in the supplemental material). CC042 mice have a white head
spot (blaze) on their forehead, a characteristic inherited from the WSB/EiJ (designated
for Watkins star blaze [WSB]) founder strain. One in every four F2 progeny carried a
blaze, confirming autosomal recessive inheritance (44). The blaze and base coat color
(black from CC001 mice or agouti from CC042 mice) assorted independently in the F2
offspring, as shown by the expected 9:3:3:1 ratio (Fig. S1). QTL mapping on the
presence or absence of white head spotting in the F2 mice identified a significant QTL
on chromosome 10 (Fig. S1). This interval contained the kit ligand (Kitl; stem cell factor),
which was previously shown to underlie this trait in the pre-CC population (44).
Next, we conducted QTL mapping on the tuberculosis-associated phenotypes,
consisting of the numbers of lung CFU, numbers of spleen CFU, and IFN- levels. Using
batch and sex as covariates, we identified four significant QTL that affect the measured
tuberculosis immunophenotypes (Tip1 to Tip4) (Table 1 and Fig. 4A and B).
The numbers of spleen CFU mapped to two distinct QTL on chromosome 7:
proximal Tip1 at 72 Mb and distal Tip2 at 125 Mb (Fig. 4C). Tip1 was inherited in an
additive fashion, with heterozygous mice carrying both the castaneous (CAST)/EiJ
(CAST) and WSB haplotypes exhibiting a phenotype intermediate to the phenotypes of
both homozygotes (Fig. 4F). In contrast, the susceptibility phenotype associated with
FIG 3 TB disease traits in a (CC001  CC042)F2 intercross population. At 28 to 31 days postinfection, the
following traits were quantified in the parental strains and the F1 and F2 offspring: the numbers of spleen
CFU (A), IFN- levels from lung homogenate (B), and the numbers of lung CFU (C). (D) The Pearson
correlation between measured traits. The distribution of each measured phenotype (numbers of
lung CFU, numbers of spleen CFU, and IFN- levels) is shown on the diagonal. Scatter plots depicting the
correlation for each pair of phenotypes are shown below the diagonal. Above the diagonal, the
correlation coefficient and significance are shown. ***, P  0.001. The data shown in all panels are for
the following population sizes: for the F2 population, n  201 total mice, n  101 females, and n  100
males; for the F1 population, n  65 total mice, n  32 females, and n  33 males; for CC001 parent mice,
n  33 total mice, n  15 females, and n  18 males; and for CC042 parent mice, n  37 total mice,
n  18 females, and n  19 males. The mice were infected in 4 batches, and values were adjusted for
batch differences using coefficients from multiple regressions.
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Tip2 was recessive, with mice homozygous for the WSB allele demonstrating a 10-fold
increase in the number of spleen CFU, on average (Fig. 4G). IFN- production in the
lung was associated with 3 distinct QTL. The main locus explained 21.4% of the
variation and was mapped to the Tip2 region on chromosome 7 (Fig. 4B), evidence that
the same variant likely controls IFN- and the bacterial burden at this locus. Two















Tip1 7 No. of spleen
CFU
104 9.2 gUNC13104259 72.1 3.6–72.9 CAST WSB Additive 17.6
Tip2 7 No. of spleen
CFU
104 12.3 gUNC13793270 125.4 124.7–127.3 NZO WSB Recessive 22.5
Tip2 7 IFN-
level
7  104 9.1 gUNC13793270 125.4 121.0–130.7 NZO WSB Recessive 21.4
Tip3 15 IFN-
level





0.046 4.2 UNC26693650 40.8 4.5–44.7 WSB CAST Additive
(nonlinear)
10.6
aLow and high haplotypes are provided at the peak logarithm of the odds (LOD) of each QTL. High and low haplotypes are provided relative to each specific trait. P
values were determined by the permutation test. The fraction of the variance explained by each QTL was estimated by fitting a single QTL model for each trait at
the respective peak locations with sex and batch as covariates. NZO, New Zealand Obese.
FIG 4 QTL mapping identifies four loci underlying TB susceptibility. (A, B) QTL scans of the numbers of lung CFU, the numbers of spleen CFU, and IFN-
abundance in the lung identify four tuberculosis immunophenotype (Tip) loci on chromosomes 7, 15, and 16. The dashed lines in panel B represent a 5% false
discovery rate for each trait based on permutation analysis. (C to E) The Tip loci on each chromosome are indicated at the marker with the peak LOD. (F to
J) Allele effect plots for the indicated Tip loci. One hundred seventy F2 mice (86 female and 84 male mice) were successfully genotyped and used for QTL
mapping.
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additional QTL were also associated with IFN- levels, mapping to chromosomes 15 and
16 (Tip3 and Tip4, respectively) (Fig. 4A and B). A second potential QTL on proximal
chromosome 16 was also associated with IFN-; however, LOD did not reach genome-
wide significance at a P value of 0.05. At Tip3, low IFN- levels were associated with
haplotypes from the CAST founder (Fig. 4D), a strain previously found to lack IFN-
expression in the lung upon infection with either M. tuberculosis or poxvirus (41, 45, 46).
Notably, Tip1 was associated with the numbers of CFU but not with IFN- levels,
indicating that this variant was functionally distinct from Tip2. No QTL were associated
with the numbers of lung CFU, suggesting that this trait is under more complex genetic
control than the others. In sum, these functionally and genetically diverse QTL indicated
that the immune response to M. tuberculosis was under multigenic control in these
strains.
Considering that both Tip1 and Tip2 are on chromosome 7 and are driven by the
WSB parent haplotype, we tested the independence of these peaks by remapping
the number of spleen CFU using the genotypes at Tip1 as a covariate. After removing
the variation explained by the proximal Tip1 QTL, the distal Tip2 QTL still met the
threshold for genome-wide significance (Fig. S2A). In addition, fitting of a three QTL
model to the number of spleen CFU phenotypes showed that Tip1, Tip2, and Tip3 all
contributed additively; removing any of them from the full model resulted in a
significantly poorer fit (Fig. S2B). Altogether, we identified four independent QTL in the
F2 cross, indicating multigenic control of M. tuberculosis immunity in this F2 population.
T cell function and recruitment are impaired in CC042 mice. Concurrently with
our genetic mapping strategy, we enumerated changes in leukocyte cell types that
could alter the susceptibility of CC042 mice relative to B6 mice. The accumulation of T
and B lymphocytes in the lungs of B6 mice began between 14 and 21 days postinfec-
tion (Fig. 5A and B). In contrast, the numbers of T and B cells in the lungs of CC042 mice
FIG 5 The susceptibility of CC042 mice correlates with altered numbers of lung leukocytes. The total numbers of the following
cells were enumerated in the lungs of B6 and CC042 mice: T cells (lymphocytes 	 single cells 	 CD3 CD19 cells) (A), B cells
(lymphocytes 	 single cells 	 CD3 CD19 cells) (B), neutrophils (single cells 	 Gr1 CD11b cells) (C), and monocytes/
macrophages (single cells 	 Gr1 CD11b cells) (D). All mice were infected in one batch, and 3 males and 3 females of each
strain were used for analysis at each time point. The data in the graphs represent the mean  SD. One-way analysis of variance
with Sidak’s multiple-comparison test was used to determine significance. **, P  0.01; ***, P  0.001; ****, P  0.0001; ns, not
significant.
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were significantly reduced. This paucity of lymphocyte accumulation in the lungs of
CC042 mice was mirrored by a dramatic increase in CD11b Gr1 granulocytes
(Fig. 5C), consistent with the neutrophilic infiltrates observed in the lung histopathol-
ogy (Fig. 2). Significant differences in the CD11b Gr1 monocyte/macrophage subset
between these mice was apparent only at the last time point, at which time the CC042
animals had become moribund (Fig. 5D).
The reduction in IFN- production and the paucity of pulmonary T cells in the lungs
of CC042 mice suggested that their susceptibility to M. tuberculosis might be related to
a defect in T cell function. To assess effector function, we isolated cells from the lungs
of infected B6 and CC042 mice and stimulated them with anti-CD3, to determine
whether T cells from CC042 mice had differentiated into a distinct T cell subset (e.g.,
Th1 versus Th2, Th17, and regulatory T cells). Using a standard intracellular cytokine
staining (ICS) approach, we found fewer CD4 and CD8 T cells from CC042 mice that
produced IFN-, tumor necrosis factor (TNF), interleukin-17a (IL-17a), IL-2, IL-10, and
CD107a upon stimulation than T cells from B6 mice (Fig. 6A and B). Thus, instead of
representing an altered T cell differentiation state, the lack of cytokine production by
T cells from the lungs of infected CC042 mice indicated that there is an impairment in
either T cell priming or recruitment of T cells to the lung.
FIG 6 CC042 mice have a defect in T cell recruitment to the lung and lack CD11a expression. (A, B) Intracellular cytokine staining (ICS) of CD4 (A) and CD8
(B) T cells reveals a defect in the number of cytokine-producing T cells in the lungs of CC042 mice. (C to E) Total number of CD4 and CD8 T cells in the lung
(C), mediastinal lymph node (D), and spleen (E). (F to H) Total number of ESAT-6 (CD4) or TB10.4 (CD8) tetramer-positive cells in the lung (F), mediastinal lymph
node (G), and spleen (H). Bar plots show the mean  SD. Welch’s t test was used to determine significance. *, P  0.05; **, P  0.01; ns, not significant. (I)
Histograms of CD4 (left) and CD8 (right) T cells stained for activation and migration markers CD44, CD62L, CD69, and CD11a for the isotype control (top, light
gray trace), CC042 mice (middle, teal trace), and B6 mice (bottom, gray trace).
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In order to distinguish between these possibilities, we counted the number of CD4
and CD8 T cells in the lung, mediastinal lymph node (mLN), and spleen at 28 days
postinfection using flow cytometry. At the same time, we enumerated the number of
antigen-specific CD4 and CD8 T cells using ESAT-6 (CD4) and TB10.4 (CD8) tetramers.
CC042 mice had fewer total CD4 and CD8 T cells in the lung than B6 mice (Fig. 6C). This
was also true in the mLN but not the spleen (Fig. 6D and E). While we saw that CC042
mice had significantly fewer ESAT-6-specific CD4 T cells and TB10.4-specific CD8 T cells
in the lung than B6 animals, both groups of mice had similar numbers of antigen-
specific T cells in the mLN and the spleen (Fig. 6F to H). When antigen-specific T cells
were considered as a fraction of the total number of T cells, the frequencies of
ESAT-6-specific T cells was similar in the lung, spleen, and mLN of B6 and CC042 mice,
while the frequency of TB10.4-specific T cells was lower in the lungs of CC042 mice than
in those of B6 mice but higher in the spleen and mLN of CC042 mice than in those of
B6 mice (Fig. S3). Taken together, this suggests that T cell priming of M. tuberculosis-
specific CD4 and CD8 T cells was occurring in the draining lymph node and that the
diminished T cell numbers in the lungs of CC042 mice is due to an impairment in T cell
recruitment. As such, we examined the cell surface expression of CD44, CD69, CD62L,
and CD11a on CD4 and CD8 T cells from the lungs of infected CC042 and B6 mice, as
these markers have been classically associated with either T cell activation or migration
(47, 48). We found that CD4 and CD8 T cells from the lungs of CC042 and B6 mice had
appropriately upregulated CD44 and CD69 and downregulated CD62L (Fig. 6I). How-
ever, CD11a was undetectable on both CD4 and CD8 T cells from CC042 mice. As CD11a
is the L component of L2, the principal 2-integrin on T cells that is crucial for
lymphocyte trafficking, this defect could explain many of the immunological differ-
ences observed between CC042 and B6 mice.
A CC042 private mutation in Itgal explains Tip2-driven susceptibility. The gene
encoding CD11a, Itgal, is located on chromosome 7, within the Tip2 locus identified in
our intercross. The lack of CD11a expression on CC042 lymphocytes implicated Itgal
variation as the basis for Tip2. To investigate this possibility, CD11a expression was
assayed in the WSB and CC011 strains, which contain the susceptibility-associated WSB
haplotype at Tip2 (Fig. 7A). We found that WSB and CC011 mouse splenocytes ex-
pressed CD11a levels similar to those expressed by B6 mouse splenocytes, leading us
to hypothesize that CC042 mice had incurred a private mutation during inbreeding that
impacts CD11a production.
Using the whole-genome sequences of representative CC strains, variants private to
each have been identified (43, 49). Using this data set, we found that the CC042 mouse
genome sequence contains a 15-bp deletion in the first intron of the Itgal1 gene which
is not present in the ancestral WSB mouse allele. This deletion alters the canonical splice
acceptor sequence (AG) at the 3= terminus of intron 1 (http://Jul2019.archive.ensembl
.org/Mus_musculus_WSB_EiJ/Transcript/Exons?dbcore;gMGP_WSBEiJ_G0032170;r
7:131372531-131430694;tMGP_WSBEiJ_T0085398). Although the resultant mutant
sequence (TG) has been observed to function as a splice acceptor in certain transcripts
(50), we hypothesized that this mutation could alter splicing. Amplification and se-
quencing of a fragment spanning exons 1 and 3 of the Itgal mRNA confirmed that the
CC042 mouse transcript lacked the exon 2 sequence that was contained in both the B6
and WSB mouse mRNAs (Fig. 7B). The lack of exon 2 is predicted to produce a
frameshift and premature termination (Fig. 7B).
While Tip2 was significantly associated only with the number of spleen CFU and lung
IFN- levels in the whole-genome scans, the lack of T cells in the lungs of CC042 animals
suggested that the CD11a deficiency also influenced bacterial replication at this site. To
test this hypothesis, we used the measured phenotypes from the F2 cross and found
that the CC042 Itgal allele was significantly associated with higher numbers of CFU in
both lung and spleen, as well as IFN production (Fig. 7C to E). This analysis indicated
that the Itgal mutation affects all metrics of tuberculosis susceptibility in CC042 mice.
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DISCUSSION
In this work, we used a classic genetic strategy to investigate the diversity of
responses to M. tuberculosis infection observed in CC strains. Previous work identified
a number of genetically dissociable immunophenotypes in M. tuberculosis-infected CC
founder lines, including bacterial load and IFN- production (41). The intercross be-
tween two phenotypically divergent CC strains reported here supports the indepen-
dence of these traits and demonstrates that multiple phenotypes can be mapped
simultaneously using this strategy. Investigating the genetic architecture of TB disease
in these highly diverse mice revealed a number of new insights that would not have
been apparent in intercrosses between more genetically homogeneous lab strains.
A loss-of-function mutation in Itgal was found to account for the Tip2 QTL and
explain a significant portion of the susceptibility of the CC042 line. This finding is
consistent with that of a concurrent study that also identified Itgal to be underlying the
susceptibility of CC042 mice to Salmonella enterica serovar Typhimurium (51). We
previously found that Itgal deletion in the B6 mouse background resulted in a defect
in T cell recruitment to the lung and an increased pulmonary M. tuberculosis burden
(21); both of these traits are associated with Itgal deficiency in the CC001  CC042
intercross. While Tip2 was significantly associated only with the number of spleen CFU
and IFN- production in whole-genome scans, the Itgal genotype also correlated with
the number of lung CFU when examined in isolation. Thus, we conclude that Itgal
affects pathogenesis in both lung and spleen and that the lack of a genome-wide
association between Itgal and the number of lung CFU is likely due to complex genetic
factors, which could include interactive effects with sex and the presence of additional
variants that dilute the effect of the Itgal mutation. In addition, the observation that the
number of lung CFU in F1 mice exceeds the range found in either parent strain suggests
FIG 7 A private mutation in Itgal in CC042 mice explains the Tip2-driven susceptibility. (A) Histograms depicting CD11a staining in CD4 (left) and CD8 (right)
T cells from B6 (gray shading), WSB (purple shading), CC011 (light blue shading), and CC042 (teal shading) mice. The isotype control antibody staining is shown
on each plot as a dotted gray trace. (B) PCR primers flanking the putative private Itgal mutation were used to amplify cDNA from B6, WSB, and CC042 mouse
RNA. PCR products were separated by gel electrophoresis on a 3% agarose gel. The second and third lanes show for B6 band WSB (the parental allele for CC042),
respectively, the 197-bp amplicons. The 100-bp size decrease in the CC042 mouse-derived product is consistent with the loss of exon 2 (fourth lane and
schematic). Sanger sequencing traces from the CC042 and WSB mouse amplicons are shown. WT, wild type; SA, splice acceptor; SV, splice variant; PTC,
premature termination codon. (C to E) TB immunophenotypes were reevaluated in F2 progeny of the CC001  CC042 mice that were homozygous for each
parental allele at the Itgal locus (probe UNC13811649): numbers of lung CFU (C), numbers of spleen CFU (D), and lung IFN- levels (E). Welch’s t test was used
to determine significance. *, P  0.05; ****, P  0.0001. Box-and-whiskers plots indicate the median and minimum-maximum values.
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a particularly complex mode of inheritance that could involve both genetic and
nongenetic factors, such as parental imprinting. Further studies, including reciprocal
crosses to account for epigenetic effects, will be necessary to understand the genetic
basis of this trait.
While the disease-promoting effect of CD11a deficiency was generally consistent
between the B6 background and the recombinant CC genotype, the loss of Itgal is
insufficient to explain the susceptibility of the CC042 strain. These CC042 mice succumb
to infection approximately 5 months earlier than Itgal/ B6 mice (21), likely due to the
more dramatic infiltration of granulocytes and the necrosis observed in the lung. The
increased susceptibility of CC042 animals can be attributed, at least in part, to Tip1.
The variant(s) underlying Tip1 appears to be functionally distinct from Itgal, as the
effects of Tip1 and Tip2 were additive, these traits differed in their mode of inheritance,
and Tip1 was not associated with IFN- levels. These data indicate that IFN--
independent mechanisms, such as those underlying Tip1, can act in an additive fashion
to increase the susceptibility of animals with a more canonical immunodeficiency that
affects Th1 cell activity.
This intercross between two very diverse genotypes allowed the mapping of QTL
that may be associated with an additional trait previously identified in the CAST
founder strain. Despite being relatively resistant to M. tuberculosis infection, CAST mice
do not produce detectable levels of IFN- in the lung (41). This observation is one of
many indicating that IFN--independent immune mechanisms play an important pro-
tective role, particularly in the lungs (27, 28, 52–54). Tip1 and Tip3 are likely related to
the IFN--deficient phenotype of CAST mice. This founder haplotype at Tip3 is associ-
ated with low levels of IFN- production, and the CAST allele at Tip1 reduces the
number of CFU without influencing IFN- levels. Defining the basis of this phenotype
might represent an important step in understanding the immune response to M.
tuberculosis in the recently identified subset of humans that control M. tuberculosis
infection in the absence of a detectable IFN- response (27).
The CC population was initially envisioned as a genetic mapping resource, based on
the random distribution of founder alleles between strains (55). While the CC panel has
been shown to be valuable for this type of study, the Itgal mutation identified in this
work was not derived from a founder line and likely occurred during the process of
inbreeding CC042 mice. Such mutations in individual CC strains provide an additional
advantage to studies within the CC: both common variants and private variants
(28,000) circulate in this population and can drive disease responses (43, 49). While
these mutations are invisible in genetic association studies that are based on a
comparison of CC lines, our work shows that their effect can be revealed through
intercrosses and that the molecular characterization of these relatively rare variants can
be rapidly achieved. This feature, in combination with the variety of phenotypes that
can be addressed in CC  CC intercrosses, highlights the value of this approach.
The immune response to M. tuberculosis in natural populations is variable. Several
lines of recent evidence suggest the importance of mechanisms distinct from canonical
Th1 immunity that dominate in the classic mouse model of TB, which relies on a small
number of genetically similar mouse lines. Using a simple intercross strategy, we
leveraged the genetic diversity of CC lines to define chromosomal loci controlling three
distinct TB-related traits: Itgal-dependent T cell recruitment (Tip2), IFN--independent
bacterial control (Tip1), and IFN- production (Tip3 and Tip4). The dissociation of
bacterial control from IFN- production was likely facilitated by the presence
of haplotypes that are absent from standard mouse strains, supporting the value of
genetic diversity to understand highly variable traits, such as TB susceptibility.
MATERIALS AND METHODS
Ethics statements and experimental animals. C57BL/6J (Jax stock number 0664) (B6) mice were
purchased from The Jackson Laboratory. CC042/GeniUnc and CC001/Unc mice were obtained from the
Systems Genetics Core Facility at the University of North Carolina (56) and bred at the University of
Massachusetts (UMass) Medical School under specific-pathogen-free conditions and in accordance with
the University of Massachusetts Medical School IACUC guidelines. F1 mice were generated from crossing
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CC001 females with CC042 males (CC001  CC042). The F2 mice used for QTL mapping were obtained
from crossing these F1 mice; e.g., all F2 animals were [(CC001  CC042)  (CC001  CC042)]F2. Two
hundred one F2 mice were made and phenotyped, and 170 were successfully genotyped and used for
QTL analysis (86 female and 84 male mice). Both female and male mice were used throughout the study,
as indicated throughout the text. All animals used for experiments were 8 to 12 weeks old.
Mycobacterium tuberculosis infection. Wild-type M. tuberculosis strain H37Rv (phthiocerol dimyco-
cerosate positive) was used for all studies. Prior to infection, the bacteria were cultured in 7H9 medium
containing 10% oleic acid-albumin-dextrose-catalase (OADC) growth supplement enrichment (Becton,
Dickinson) and 0.05% Tween 80. For aerosol infections, bacteria were resuspended in phosphate-
buffered saline (PBS) containing Tween 80 (PBS-T). Prior to infection, the bacteria were sonicated and
then delivered via the respiratory route using an aerosol generation device (Glas-Col). Groups of mice
were sacrificed at 24 h postinfection to enumerate the infectious dose. The infectious dose for all
experiments ranged from 50 to 150 CFU.
CFU enumeration and cytokine quantification. To determine the number of CFU, mice were
anesthetized via inhalation with isoflurane (Piramal) and euthanized via cervical dislocation. The organs
were aseptically removed and individually homogenized, and viable bacteria were enumerated by
plating 10-fold serial dilutions onto 7H10 agar plates. The plates were incubated at 37°C, and the colonies
were counted after 21 days. Cytokine concentrations in cell-free lung homogenates were quantified
using commercial enzyme-linked immunosorbent assay (ELISA) kits (IFN- Duo Set; catalog number
DY485; R&D Systems) according to the manufacturer’s instructions.
Histology. Lung lobes from B6 and CC042 mice infected with M. tuberculosis were fixed in 10%
neutral buffered formalin, embedded in paraffin, and sectioned at 5 m. The sections were stained with
hematoxylin and eosin (H&E). All sectioning and staining were done by the Diabetes and Endocrinology
Research Center Morphology Core (DERC) at the University of Massachusetts Medical School. Images
were captured on a TissueGnostics TissueFAXS Plus slide scanning microscope at 2 and 20 magni-
fications.
Flow cytometry analysis. Lung tissue was harvested in RPMI containing fetal bovine serum (FBS)
and placed in C tubes (Miltenyi). Collagenase type IV/DNase I was added, and the tissues were dissociated
for 10 s on a GentleMACS system (Miltenyi). The tissues were incubated for 30 min at 37°C with
oscillations and then dissociated for an additional 30 s on a GentleMACS system. Lung homogenates
were passed through a 70-m-pore-size filter. Cell suspensions were washed in RPMI, passed through a
40-m-pore-size filter, and aliquoted into 96-well plates for flow cytometry staining. Nonspecific anti-
body binding was first blocked using the Fc Block reagent, after which the cells were then stained with
CD3-BV785 (clone 145-2CL1), CD8-allophycocyanin (APC)-Fire 750 (clone 53-8.7), CD44-peridinin chloro-
phyll protein-Cy5.5 (clone IM7), CD11a-BV711 (clone M17/4), CD69-phycoerythrin (PE)-Cy7 (clone H1.2F3),
and CD62L-BV570 (clone MEL-14) from BioLegend and CD4-Alexa Fluor 700 (clone RM4-5) from BD
Biosciences. In some experiments, intracellular cytokine staining was also performed. After surface
marker staining, cells were subsequently permeabilized using Cytofix/Cytoperm solution (BD Biosciences)
and stained with IFN-APC (clone XMG1.2), IL-2 PE-Cy7 (clone JES6-5H4), IL-17a-BV650 (clone TC11-
18H10.1), TNF-BV421 (clone MP6-XT22), IL-10 (clone JES5-16E3), and CD107a-PE (clone 1D4B) from
BioLegend and IL-4-Alexa Fluor 488 (clone 11B11) from Invitrogen. Live cells were identified using fixable
Live/Dead Aqua stain (Life Technologies). The cells were stained for 30 min at room temperature and
fixed in 1% paraformaldehyde for 60 min. All flow cytometry assays were run on either a MACSQuant
Analyzer 10 (Miltenyi) or Aurora (Cytek) flow cytometer, and the results were analyzed using FlowJo
(version 10) software (TreeStar).
Genotyping and QTL mapping. DNA (1,500 ng) was genotyped by Neogen Inc. using the MiniMUGA
array. We filtered markers to those that were consistent within a previously published set of CC042 and
CC001 mouse genotypes (43) and diagnostic between these strains (i.e., a CC001 genotype that was not
equal to the CC042 genotype and F1 genotype was called heterozygous). After finding and removing
misplaced markers, identified using the droponemarker function of the R package qtl (R/qtl), regions of
dense marker coverage were thinned to a spacing of 0.1 cM. The final genetic map contained 1,806
markers. Genotype and phenotype data are available in Tables S1 and S2 in the supplemental material.
Genotype and phenotype data were imported into R (version 3.4.3) and reformatted for R/qtl (version
1.42-8). Genotype probabilities were calculated at a 0.25-cM spacing, and QTL mapping was carried out
using the scanone function and batch and sex as additive covariates. Significant LOD thresholds were
established by a permutation test with 10,000 permutation replicates. Multi-QTL models were fit using
R/qtl’s fitqtl function. LOD profiles and effect plots were generated using the plotting functions of the
R/qtl package.
Ex vivo RNA isolation and qRT-PCR. Bone marrow-derived macrophages (BMDMs) from B6, WSB,
and CC042 mice were generated. Briefly, marrow was isolated from the femurs and tibias of age- and
sex-matched mice and cultured in high-glucose Dulbecco modified Eagle medium (catalog number
11965092; Gibco) supplemented with L-glutamine, 10% fetal bovine serum (FBS; catalog number F4135;
Sigma), and 20% L929 conditioned medium. After 7 days, differentiated cells were lifted with PBS with
10 mM EDTA and seeded for subsequent experimentation. RNA was isolated by lysing the cells in the
TRIzol reagent (catalog number 15596018; Thermo Fisher) and purified using a Direct-zol RNA Miniprep
plus kit (catalog number R2070; Zymo Research) per the manufacturer’s recommendations. Following
RNA quantification with a NanoDrop spectrophotometer, samples were diluted to 5 ng/l and used for
quantitative reverse transcription-PCR (qRT-PCR) with a Luna One-Step Universal quantitative PCR kit
(catalog number E3005; New England Biolabs). Gene-specific primers for target transcripts were used at
a final concentration of 400 M with 15 ng of RNA. Primer sequences for Itgal (primer RT-Itgal_1F,
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5=-CCAGACTTTTGCTACTGGGAC-3=; primer RT-Itgal_1R, 5=-GCTTGTTCGGCAGTGATAGAG-3=) were de-
signed using publicly available genomic sequences for B6, WSB, and CC042 mice (49). Itgal PCR products
were separated by gel electrophoresis on a 3% agarose gel, and their sequences were determined by
Sanger sequencing.
Statistical analysis. Statistical tests were performed using GraphPad Prism (version 7) software. The
correlation between measured traits was visualized using the chart correlation function in the Perfor-
manceAnalytics package in R (version 3.2.4) software.
Data availability. All relevant data to support the findings of this study are located within the paper
and supplemental files.
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